Abstract 5863: RGX-202, a first-in-class small-molecule inhibitor of the creatine transporter SLC6a8, is a robust suppressor of cancer growth and metastatic progression
2010 ◽
Vol 9
(5)
◽
pp. 1136-1146
◽
Keyword(s):
2020 ◽
Vol 522
(3)
◽
pp. 633-638
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 13
(3)
◽
pp. 565-575
◽
Keyword(s):
Keyword(s):